Unlock instant, AI-driven research and patent intelligence for your innovation.

Docetaxel liposome containing chitosan derivative, lyophiled preparation and preparation method thereof

A technology of chitosan derivatives and docetaxel, applied in liposome delivery, medical preparations containing active ingredients, medical preparations with non-active ingredients, etc. The method is not suitable for industrialized large-scale production, poor liposome stability and other problems, and achieves the effects of reducing unsafe factors, reducing dosage and high stability

Inactive Publication Date: 2008-01-30
CHINA PHARM UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

People such as Maria laura Immordino have reported a kind of docetaxel liposome, but this liposome stability is poor because of technical reason, just leaks more than 50% in one day at 4 ℃, and its liposome production method is not suitable for industrialized large-scale production ( Maria laura Immordino, Paola Brusa, J.Journal of Controlled Release, 91(2003) 417-429), more unsuitable for clinical use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Docetaxel liposome containing chitosan derivative, lyophiled preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Weigh 15mg of docetaxel, 375mg of lecithin and 45mg of cholesterol and dissolve them in 10ml of ethanol solution, mix well after passing through nitrogen gas, drain the ethanol with a rotary evaporator in a water bath at a temperature of 45°C, and form a uniform phospholipid film, use Phosphate buffer solution of pH7.4 was used to elute 10ml of phospholipid membrane. The obtained liposome suspension was poured into an APV2000 homogenizer, homogenized 5 times under the pressure of the primary valve 1760bar and the secondary valve 270bar, and then extruded through the extruder with a 200nm filter membrane. After the liposome suspension is prepared, 50 mg of palmitic acid acylated chitosan is dissolved and dispersed uniformly with an acetic acid solution of pH 6.5. The liposome suspension was flushed with nitrogen gas and stirred slowly at room temperature, then dropped into the liposome suspension at a constant speed, and incubated at room temperature for 1 hour after the...

Embodiment 2

[0048] Weigh 10mg of docetaxel, 200mg of soy lecithin, 50mg of PEG-DSPE and 30mg of cholesterol and dissolve in 10ml of ether solution, slowly lower the solution into 10ml of pH7.4 phosphate buffer, and evaporate the ether at room temperature. The obtained liposome suspension was poured into an APV2000 homogenizer, homogenized 5 times under the pressure of the primary valve 1760bar and the secondary valve 270bar, and then extruded through the extruder with a 200nm filter membrane. After the liposome suspension is prepared, 40 mg of the stearic acid acylated chitosan is dissolved and dispersed uniformly with an acetic acid solution of pH 6.5. The liposome suspension was flushed with nitrogen gas and stirred slowly at room temperature, then dropped into the liposome suspension at a constant speed, and incubated at room temperature for 1 hour after the dropwise addition to obtain a suspension for use. The phosphate buffer solution with pH 7.5 is added to the suspension and mixed,...

Embodiment 3

[0050] Weigh 10mg of docetaxel, 500mg of lecithin and 40mg of cholesterol and dissolve in 15ml of ethanol solution, drop the solution into 8ml of phosphate buffer solution with pH 7.4 slowly at a uniform speed, and evaporate the ethanol at room temperature. The obtained liposome suspension was poured into an APV2000 homogenizer, homogenized 5 times under the pressure of the primary valve 1760bar and the secondary valve 270bar, and then extruded through the extruder with a 200nm filter membrane. After the liposome suspension is prepared, 40 mg of lauric acid acylated chitosan is dissolved and dispersed evenly with 5 ml of acetic acid solution of pH 6.8. The liposome suspension was flushed with nitrogen gas and stirred slowly at room temperature, dropped into the liposome suspension at a constant speed, and incubated at room temperature for 2 hours after the dropwise addition to obtain a suspension for use. The phosphate buffer solution with pH 7.5 is added to the suspension and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a docetaxel liposome containing chitosan derivative, lyophiled preparation and preparation method, which comprises Docetaxel 1 part, chitosan derivative 1-10 parts, phospholipids 10-50 parts, and cholesterin 1-10 parts, The invention realizes stabilized quality, higher encapsulation efficiency and better effect.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a chitosan derivative-modified docetaxel liposome, a freeze-dried preparation and a preparation method. Background technique [0002] Docetaxel (also known as docetaxel, English name docetaxel) is a derivative of paclitaxel, which is clinically used to treat breast cancer and non-small cell cancer, and is effective for lung cancer, ovarian cancer, pancreatic cancer, gastric cancer and head and neck cancer. It is used for the treatment of advanced or metastatic breast cancer who failed prior chemotherapy and advanced or metastatic non-small cell lung cancer who failed cisplatin-based chemotherapy. The US FDA approved docetaxel plus cisplatin on July 15, 2002 as a first-line regimen for advanced non-small cell lung cancer. The mechanism of action of docetaxel is to enhance tubulin polymerization and inhibit tubulin depolymerization, resulting in the formation of stable n...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/337A61K9/127A61K47/36A61P35/00
Inventor 朱家壁葛亮
Owner CHINA PHARM UNIV